Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gilla Kaplan currently holds 24,600 shares of Tyra Biosciences, Inc. (TYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gilla Kaplan has been a net seller of TYRA stock. They have purchased $0 and sold $51.6M worth of shares.
Gilla Kaplan's most recent insider trade was on Aug 13, 2024, when they sold 24,600 shares at $0.00 per share.
Gilla Kaplan serves as Executive at Tyra Biosciences, Inc. (TYRA). They have executed 76 insider transactions totaling $51.6M over their tenure at the company.
Gilla Kaplan holds the position of Executive at Tyra Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gilla Kaplan has shown a selling trading pattern, with $0 in total purchases and $51.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gilla Kaplan was on Jan 2, 2015, when they sold $5.2M worth of CELG shares. This transaction involved 45,536 shares at $113.47 per share.
Gilla Kaplan currently owns 24,600 shares of Tyra Biosciences, Inc. (TYRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gilla Kaplan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gilla Kaplan has 76 Form 4 filings on record as an insider at Tyra Biosciences, Inc..
Set alerts for Gilla Kaplan and 40,000+ other insiders.